Hyperlipidaemia impairs the circadian clock and physiological homeostasis of vascular smooth muscle cells via the suppression of Smarcd1

Journal of Pathology

Volumn 233, Issue 2, 2014, Pages 159-169

  Chen, Siyu ^a   Ding, Yan ^a   Zhang, Zhao ^a   Wang, Han ^b   Liu, Chang ^a  

^a NANJING NORMAL UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

circadian clock; hyperlipidaemia; physiology; smarcd1; vascular smooth muscle cells

Indexed keywords

CELL NUCLEUS RECEPTOR; NUCLEAR ORPHAN RECEPTOR ALPHA; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN BMAL1; SMARCD1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE CHECKPOINT; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENZYME ACTIVATION; HOMEOSTASIS; HYPERLIPIDEMIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

CIRCADIAN CLOCK; HYPERLIPIDAEMIA; PHYSIOLOGY; SMARCD1; VASCULAR SMOOTH MUSCLE CELLS;

ANIMALS; AORTA, THORACIC; ARNTL TRANSCRIPTION FACTORS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CIRCADIAN CLOCKS; CLOCK PROTEINS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DOWN-REGULATION; ENZYME ACTIVATION; FATTY ACIDS; HOMEOSTASIS; HYPERLIPIDEMIAS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84900823255     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4338     Document Type: Article

References (45)

1. Rutter J, Reick M, McKnight SL,. Metabolism and the control of circadian rhythms. Annu Rev Biochem 2002; 71: 307-331.
2. King DP, Takahashi JS,. Molecular genetics of circadian rhythms in mammals. Annu Rev Neurosci 2000; 23: 713-742.
3. Wijnen H, Young MW,. Interplay of circadian clocks and metabolic rhythms. Annu Rev Genet 2006; 40: 409-448.
4. Lin JD, Liu C, Li S,. Integration of energy metabolism and the mammalian clock. Cell Cycle 2008; 7: 453-457.
5. Schibler U, Sassone-Corsi P,. A web of circadian pacemakers. Cell 2002; 111: 919-922.
6. Zylka MJ, Shearman LP, Levine JD, et al., Molecular analysis of mammalian timeless. Neuron 1998; 21: 1115-1122.
7. Kume K, Zylka MJ, Sriram S, et al., mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999; 98: 193-205.
8. Preitner N, Damiola F, Lopez-Molina L, et al., The orphan nuclear receptor REV-ERBα controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002; 110: 251-260.
9. Sato TK, Panda S, Miraglia LJ, et al., A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 2004; 43: 527-537.
10. Doi M, Takahashi Y, Komatsu R, et al., Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 2010; 16: 67-74.
11. Anea CB, Zhang M, Stepp DW, et al., Vascular disease in mice with a dysfunctional circadian clock. Circulation 2009; 119: 1510-1517.
12. Chomiki N, Henry M, Alessi MC, et al., Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls. Thromb Haemost 1994; 72: 44-53.
13. Vaughan DE,. PAI-1 and atherothrombosis. J Thromb Haemost 2005; 3: 1879-1883.
14. Wang J, Yin L, Lazar MA,. The orphan nuclear receptor Rev-erbα regulates circadian expression of plasminogen activator inhibitor type 1. J Biol Chem 2006; 281: 33842-33848.
15. Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
16. Nonaka H, Emoto N, Ikeda K, et al., Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells. Circulation 2001; 104: 1746-1748.
17. Reilly DF, Westgate EJ, FitzGerald GA,. Peripheral circadian clocks in the vasculature. Arterioscler Thromb Vasc Biol 2007; 27: 1694-1705.
18. Wang W, Xue Y, Zhou S, et al., Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev 1996; 10: 2117-2130.
19. Gatfield D, Le Martelot G, Vejnar CE, et al., Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev 2009; 23: 1313-1326.
20. Tao W, Chen S, Shi G, et al., SWItch/sucrose nonfermentable (SWI/SNF) complex subunit BAF60a integrates hepatic circadian clock and energy metabolism. Hepatology 2011; 54: 1410-1420.
21. Yang R, Le G, Li A, et al., Effect of antioxidant capacity on blood lipid metabolism and lipoprotein lipase activity of rats fed a high-fat diet. Nutrition 2006; 22: 1185-1191.
22. Gordon D, Mohai LG, Schwartz SM,. Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells. Circ Res 1986; 59: 633-644.
23. Gaster M, Rustan AC, Beck-Nielsen H,. Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes. Diabetes 2005; 54: 648-656.
24. Haourigui M, Martin ME, Thobie N, et al., Stimulation of the binding properties of adult rat corticosteroid-binding globulin by a lipolysis-induced rise in plasma free fatty acids. Endocrinology 1993; 133: 183-191.
25. Balsalobre A, Damiola F, Schibler U,. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 1998; 93: 929-937.
26. Liu C, Li S, Liu T, et al., Transcriptional coactivator PGC-1α integrates the mammalian clock and energy metabolism. Nature 2007; 447: 477-481.
27. Li S, Liu C, Li N, et al., Genome-wide coactivation analysis of PGC-1α identifies BAF60a as a regulator of hepatic lipid metabolism. Cell Metab 2008; 8: 105-117.
28. Hunt T, Sassone-Corsi P,. Riding tandem: circadian clocks and the cell cycle. Cell 2007; 129: 461-464.
29. Kim S, Iwao H,. Stress and vascular responses: mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling. J Pharmacol Sci 2003; 91: 177-181.
30. Muto A, Fitzgerald TN, Pimiento JM, et al., Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons. J Vasc Surg 2007; 45 (suppl A): A15-24.
31. Bultman S, Gebuhr T, Yee D, et al., A Brg1-null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 2000; 6: 1287-1295.
32. Muchardt C, Yaniv M,. When the SWI/SNF complex remodels the cell cycle. Oncogene 2001; 20: 3067-3075.
33. de la Serna IL, Carlson KA, Imbalzano AN,. Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. Nat Genet 2001; 27: 187-190.
34. Lee D, Kim JW, Seo T, et al., SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem 2002; 277: 22330-22337.
35. Klochendler-Yeivin A, Muchardt C, Yaniv M,. SWI/SNF chromatin remodeling and cancer. Curr Opin Genet Dev 2002; 12: 73-79.
36. Ito T, Yamauchi M, Nishina M, et al., Identification of SWI-SNF complex subunit BAF60a as a determinant of the transactivation potential of Fos/Jun dimers. J Biol Chem 2001; 276: 2852-2857.
37. van de Wijngaart DJ, Dubbink HJ, Molier M, et al., Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression. Mol Endocrinol 2009; 23: 1776-1786.
38. Storch KF, Lipan O, Leykin I, et al., Extensive and divergent circadian gene expression in liver and heart. Nature 2002; 417: 78-83.
39. Akhtar RA, Reddy AB, Maywood ES, et al., Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr Biol 2002; 12: 540-550.
40. Panda S, Antoch MP, Miller BH, et al., Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002; 109: 307-320.
41. Hou L, Lu C, Huang Y, et al., Effect of hyperlipidemia on the expression of circadian genes in apolipoprotein E knock-out atherosclerotic mice. Lipids Health Dis 2009; 8: 60.
42. Garcia-Rios A, Perez-Martinez P, Delgado-Lista J, et al., A Period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndrome. J Nutr 2012; 142: 1213-1218.
43. Chalmers JA, Martino TA, Tata N, et al., Vascular circadian rhythms in a mouse vascular smooth muscle cell line (Movas-1). Am J Physiol Regul Integr Comp Physiol 2008; 295: R1529-1538.
44. Rensen SS, Doevendans PA, van Eys GJ,. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Netherlands Heart J 2007; 15: 100-108.
45. Anea CB, Ali MI, Osmond JM, et al., Matrix metalloproteinase 2 and 9 dysfunction underlie vascular stiffness in circadian clock mutant mice. Arterioscler Thromb Vasc Biol 2010; 30: 2535-2543.